Optimistic assessment of the Information and Knowledge Center at the National Security Agency: The success of Pfizer's vaccine, which works in a similar way to Moderna's, raises the chance that the vaccines will arrive in Israel earlier than expected.
The modernity vaccine
Photography:
Reuters
Providing a modern vaccine dose in Michigan
Photography:
AFP - Archive
Information and Knowledge Center staff
Photography:
Oren Cohen - Archive
"If the modern results of Moderna are similar to those of Pfizer, it is likely that by the end of 2020 there will be at least two vaccines approved for use against the corona,"
reads a report released today (Wednesday) by the Information and Knowledge Center. Morbidity trends in Israel and around the world.
As you may recall, Pfizer announced two days ago that the vaccine he developed is effective in about 90% of cases - a figure that is significantly higher than expected.
Unlike Pfizer, Pfizer has no agreement to distribute the vaccine with Israel.
The agreement with Moderna was signed in June.
The company's CEO Stephen Bensell announced in early October that the vaccine's development rate was progressing as expected and the results so far were encouraging, but mass distribution may be delayed. He said that towards the end of November the company will ask the US Food and Drug Administration (FDA) for emergency approval to distribute the vaccine. Will be given in April 2021.
Photo: GPO
The report qualifies Pfizer and its German partner for the breakthrough achieved, because it "relies on data that has not yet been published and has not been peer-reviewed, nor does it contain clear data to test whether it is a vaccine that prevents vaccination of the vaccinated (and consequently their environment). "Or is it a vaccine that prevents only disease, and in particular a serious illness - a fact that is of crucial importance for the containment and restraint of the epidemic."
It was also noted: "It is worth noting that the vaccine faces several complex obstacles before it is widely used, along with actual information gaps regarding the extent of its effect on the actual course of the epidemic."